RXO INC RXO
19.79
(0.14)
(0.70%)
as of 25 Sep
- Market cap
- $3.3B
- P/E
- 0.0×
Follow RXO
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (6.79%) | (6.78%) | (6.34%) | (4.89%) |
+8 more TTM periods Free account |
|
| (3.15%) | (3.20%) | (2.99%) | (2.40%) | ||
ROIC |
(2.39%) | (3.46%) | (3.34%) | (2.59%) | |
Return on Tangible Assets |
(23.08%) | (25.12%) | (24.21%) | (18.33%) | |
Average Days of Receivables |
86.56 | 77.41 | 77.93 | 67.84 | |
Free Cash Flow per Share |
(0.44) | (0.08) | (0.04) | (0.10) | |
Free Cash Flow |
(75.00) | (13.00) | (6.00) | (17.00) | |
Capital Expenditures |
(58.00) | (59.00) | (57.00) | (54.00) | |
Piotroski F-Score |
2.00 | 3.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(0.84%) | 2.33% | 2.60% | 1.84% | |
Accounts Receivable Turnover |
4.85 | 4.85 | 4.68 | 5.30 | |
Accounts Payable Turnover |
8.83 | 8.91 | 8.67 | 9.42 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
50.23 | 44.21 | 40.98 | 35.41 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.15) | (0.16) | (0.13) | (0.19) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.40% | 14.28% | 14.49% | 14.31% | |
Share Based Compensation of Revenue |
0.48% | 0.51% | 0.51% | 0.47% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.16 | (0.44) | (0.51) | (0.47) | |
Depreciation/Fixed assets |
0.84 | 0.84 | 0.87 | 0.88 | |
Capex/Depreciation |
(0.55) | (0.54) | (0.49) | (0.45) | |
Revenue per Share |
35.89 | 33.91 | 34.08 | 35.24 | |
Operating CF per Share |
(0.10) | 0.27 | 0.30 | 0.22 | |
Capex per Share |
(0.34) | (0.35) | (0.34) | (0.32) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
(1.72%) | (1.83%) | (1.74%) | (1.33%) |
Columns are period end dates